Talis Biomedical Q4 EPS $(7.39) Up From $(15.15) YoY, Sales $195.00K Down From $257.00K YoY

Talis Biomedical Corp. -1.11%

Talis Biomedical Corp.

TLIS

8.90

-1.11%

Talis Biomedical (NASDAQ: TLIS) reported quarterly losses of $(7.39) per share. This is a 51.22 percent increase over losses of $(15.15) per share from the same period last year. The company reported $195.00 thousand in sales this quarter. This is a 24.12 percent decrease over sales of $257.00 thousand the same period last year.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via